Gloiopeltis furcata (POSTELS et RUPRECHT) J. AGARDH is a perennial red alga (Rhodophyta) which belongs to the Endocladiaceae family and distributed in the north coast of Pacific, including Korea and Japan. Many reports have been published highlighting the variety of its biological activities, such as cancer prevention, 1) constipation improvement, 1) radical scavenging, 2,3) removement of cholesterol, 4) recalcification of tooth, 5) tyrosinase inhibition, 6) hair growth inhibition, 7) antitumor, 8) antibacterial, 9) antiaging and wrinkle prevention, 10) anti oral bacteria, 11) b-D-glucosidase inhibition, 12) and blood anticoagulation 13) from G. furcata. However, limited studies are available on the derived chemicals of this maritime plant, except for the studies on galactan and polysaccharides.
Gloiopeltis furcata (POSTELS et RUPRECHT) J. AGARDH is a perennial red alga (Rhodophyta) which belongs to the Endocladiaceae family and distributed in the north coast of Pacific, including Korea and Japan. Many reports have been published highlighting the variety of its biological activities, such as cancer prevention, 1) constipation improvement, 1) radical scavenging, 2, 3) removement of cholesterol, 4) recalcification of tooth, 5) tyrosinase inhibition, 6) hair growth inhibition, 7) antitumor, 8) antibacterial, 9) antiaging and wrinkle prevention, 10) anti oral bacteria, 11) b-D-glucosidase inhibition, 12) and blood anticoagulation 13) from G. furcata. However, limited studies are available on the derived chemicals of this maritime plant, except for the studies on galactan and polysaccharides. 14) Alzheimer's disease (AD) is a chronic neurodegenerative disorder that damages the brain and results in cognitive impairment, including memory loss and learning disturbances commonly seen in the elderly. 15, 16) Many different theories have been postulated for the etiology of AD and one of the well-established theories suggests the involvement of cholinergic pathway, indicating that progressive decline in the levels of neurotransmitter acetylcholine as the culminating process for development of AD. 17) AD is also characterized pathologically by the presence of amyloid plaques and tauassociated neurofibrillary tangles, which are commonly related to the states of oxidative stress, such as exposure to peroxynitrite (ONOO Ϫ ) and superoxide anion ( · O 2 Ϫ ). 18) Thus, this research was done to determine effectiveness as cholinesterases (ChEs) inhibitors by alleviating the cholinergic deficits improving neurotransmission and utilize its antioxidant property to ameliorate oxidative stress.
Limited studies have been conducted and reported that highlights the chemical constituents anticholinesterase and antioxidant activities of G. furcate. This work focuses on the isolation and characterization of bioactive constituents of G. furcata to evaluate of anticholinesterase and antioxidant activities via inhibitory activities on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) and scavenging activities on 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and ONOO Ϫ , respectively.
Results and Discussion
G. furcata was extracted with 95% ethanol (EtOH) and concentrated in vacuo. The EtOH extract of G. furcata was subsequently fractionated into five parts: n-hexane, methylene chloride (CH 2 Cl 2 ), ethyl acetate (EtOAc), n-butanol (BuOH) and water. Anticholinesterase and antioxidant activities of these fractions were examined via inhibitory activities on AChE and BChE as well as scavenging activities on DPPH radical and ONOO Ϫ . The results showed that the EtOAc fraction had the strongest DPPH radical and ONOO Ϫ scavenging activities; while n-hexane and EtOAc fractions had BChE inhibitory activity.
Chromatographic separation of the EtOAc, CH 2 Cl 2 , and nhexane fractions yielded eighteen compounds, including 1-10 from the EtOAc fraction, 11-14 from the CH 2 Cl 2 fraction, and 15-18 from the n-hexane fraction by RP-C18 and silica gel, Sephadex LH-20 gel column, and HPLC chromatographies.
The electron ionization-mass spectra (EI-MS) spectral analysis of 1 showed a [M] ϩ at m/z 160 and HR-FAB-MS spectral analysis showed a [MϩH] ϩ at m/z 161.0448 corresponding to the molecular formula C 6 In HMBC spectrum (Fig. 2 ) of 1, connectivity was observed between C-1 and H-2ab, between C-5Ј and H-4Ј, and between C-3Ј and H-2Јab, H-4Јab and H-2ab. The correlation in the COSY spectrum (Fig. 2 ) displayed connectivity between H-2Јab, H-2ab and H-4Јab. Therefore, the structure of 1 was determined as 2-(3-hydroxy-5-oxotetrahydrofuran-3-yl)acetic acid. The absolute configuration of 1 remains unknown. Compound 1 was first isolated from natural sources, and its physicochemical data have never been reported previously. Although isolation of methyl ester of 1 was reported, [a] D 25 Ϫ3.0°(cϭ0.3, CHCl 3 ), its absolute configuration remained also unknown. 19) The FAB-MS spectral analysis of 11 showed a [MϩH] ϩ at m/z 183.1 and HR-FAB-MS spectral analysis of 11 showed a [MϩH] ϩ at m/z 183.1021 corresponding to the molecular formula C 10 Proton and carbon signals were assigned with the help of HSQC, HMBC and COSY experiments. In HMBC spectrum (Fig. 3 ) of 11, connectivities were observed between C-1 and H-2 and H-3, between C-9 and H-7, H-8 and H-10, and between C-5 and H-7, H-6, H-4 and H-3, between C-8 and H-7, H-6 and H-10, and between C-1 and H-2 and H-3. The correlation in the COSY spectrum (Fig. 3) displayed connectivity between H-5 and H-4, H-6, between H-8 and H-7, H-6, between H-3 and H-2, H-4. Therefore, the structure of 11 was determined as (5E,7E)-9-oxodeca-5,7-dienoic acid. Compound 11 is a new compound.
Known compounds 2-10 and 12-18 were determined by direct comparison with authentic samples, or by comparing their physical and spectral data with those in the literature: 2-(3-hydroxy-5-oxotetrahydrofuran-3-yl)acetic acid 20) ( (18) . All the compounds were isolated for the first time from this plant.
The anticholinesterase and antioxidant activities of 1-18 General Procedures Melting point was measured using Yanaco micro melting point apparatus (Kyoto, Japan). Optical rotation was measured using Jasco DIP-370 digital polarimeter (Tokyo, Japan). UV spectra were measured on Shimadzu UV-160A spectrometer (Kyoto, Japan). IR (KBr disk) spectra were measured on Mattson Genesis II (Madison, WI, U.S.A.) and Jasco-300E FT-IR spectrophotometers (Tokyo, Japan). EI-MS and HR-FAB-MS were performed with a Quattro II spectrometer (Micromass, Altrincham, U.K.). The NMR spectra were recorded in CD 3 OD, CDCl 3 and C 5 D 5 N on Varian OXFORD-AS400 MHz instrument (Palo Alto, CA, U.S.A.).
Measurement of DPPH Radical Scavenging Activity
The DPPH radical scavenging effect was evaluated using method reported earlier by Blois with suitable modifications.
37) The reduction of DPPH as indicated below was followed by monitoring its decrease in absorbance at a characteristic wavelength during the reaction. In its radical form, DPPH absorbs at 520 nm, but after reduction by an antioxidant or a radical species, the absorption disappears. One hundred sixty microliters of a MeOH solution (final concentration 50 mg/ml) was added to 40 ml DPPH methanol solution (1.5ϫ10 Ϫ4 M). After gentle mixing and allowing it to stand at room temperature for 30 min, the optical density was measured at 530 nm using a microplate reader spectrophotometer VERSAmax (Molecular Devices, CA, U.S.A.). The antioxidant activity of each sample was expressed in term of the IC 50 (mg/ml required to inhibit DPPH radical formation by 50%), which was calculated from the log-dose inhibition curve. L-Ascorbic acid was used as a positive control.
Measurement of the ONOO ؊ Scavenging Activity The ONOO Ϫ scavenging was measured by monitoring the oxidation of DHR 123 using the method described by Kooy et al. with suitable modifications. 38) DHR 123 (5 mM) in dimethylformamide, which was purged with nitrogen, was stored at Ϫ80°C as a stock solution. This solution was then placed in ice and was protected from direct light until prior to the study. The samples were dissolved in 10% dimethyl sulfoxide (DMSO) (f.c. 50 mg/ml). The buffer used was consisted of 90 mM sodium chloride, 50 mM sodium phosphate, 5 mM potassium chloride at pH 7.4, and 100 mM diethylenetriaminepentaacetic acid (DTPA), each of which was prepared with high quality deionized water and was purged with nitrogen. The final concentration of DHR 123 was of Measurement of Cholinesterases Inhibitory Activity For the inhibitory activities against ChEs were measured using the spectrophotometric method developed by Ellman et al. 39) ACh (acetylcholine) and BCh (butyrylcholine) were used as substrates to assay the inhibitions of AChE and BChE, respectively. The reaction mixture contained: 140 ml of sodium phosphate buffer (pH 8.0), 20 ml of test sample solution and 20 ml of either AChE or BChE solution, which were mixed and incubated for 15 min at room temperature. The reactions were initiated with the addition of 10 ml of dithiobisnitrobenzoate (DTNB) and 10 ml of either ACh or BCh, respectively. The hydrolysis of ACh or BCh was monitored after the formation of yellow 5-thio-2-nitrobenzoate anion at 412 nm for 15 min, which resulted from the reaction of DTNB with thiocholine, released by enzymatic hydrolysis of either ACh or BCh, respectively. Test samples and the positive control (galanthamine) were dissolved in 10% analytical grade ethanol. All reactions were performed in triplicate in 96-well microplates, using VERSAmax (Molecular Devices, CA, U.S.A.). The percentage (%) inhibition was calculated from (EϪS)/Eϫ100, where E and S are the enzyme activities without and with the test sample, respectively. The ChEs inhibitory activity of each sample was expressed in terms of IC 50 value (mg/ml required to inhibit the hydrolysis of the substrate; ACh or BCh, by 50%), as calculated from the log-dose inhibition curve.
Extraction and Isolation G. furcata (30 kg) was cut into small pieces and extracted with 95% EtOH at 80°C to yield 1.9 kg of extract after removal of the solvent. The EtOAc soluble fraction (13.4 g) was subjected to open column chromatography over silica gel (60 g) eluted with hexane-acetone and acetone-MeOH gradient. Fractions (GF-EA-A to GF-EA-Y) were collected and pooled according to their similar TLC patterns. Fraction GF-EA-XY (756 mg) was chromatographed on a reverse-phase column (2.0ϫ50 cm, RP-C18) with MeOH-H 2 O (gradient from 15 : 85 to 30 : 70) to afford GF-EA-XY-1, GF-EA-XY-2 and GF-EA-XY-20. GF-EA-XY-2 was purified with reverse-phase column (1.2ϫ45 cm, RP-C18) with MeOH-H 2 O (15 : 85) to afford 2-(3-hydroxy-5-oxotetrahydrofuran-3-yl)acetic acid (1, 20 mg). GF-EA-XY-20 was purified with reverse-phase column (1.2ϫ45 cm, RP-C18) with MeOH-H 2 O (15 : 85) to afford nicotinic acid (4, 37 mg). GF-EA-XY-1 was purified with reverse-phase column (1.2ϫ45 cm, RP-C18) with MeOH-H 2 O (20 : 80) to afford glycerol (9, 50 mg). Fraction GF-EA-Q (1.2 g) was chromatographed on a reverse-phase column (2.0ϫ40 cm, RP-C18) with MeOH-H 2 O (gradient from 15 : 85 to 100 : 0) to fractionated GF-EA-Q-A to GF-EA-Q-F. Fractions GF-EA-Q-B and GF-EA-R were recrystallized to afford glutaric acid (2, 50 mg) and succinic acid (3, 100 mg), respectively. Fraction GF-EA-Q-C was chromatographed with silica gel column (1.2ϫ40 cm) with n-hexane-acetone (5 : 1) to afford 7-hydroxy cholesterol (7, 29 Fraction GF-EA-Z (202.1 mg) was chromatographed on a silica gel column (1.5ϫ70 cm) with n-hexane-acetone (7 : 1) to afford GF-EA-Z-12. GF-EA-Z-12 (50 mg) was purified with silica gel column (1.3ϫ45 cm) with nhexane-acetone (4 : 1) to afford uridine (8, 10 mg).
The CH 2 Cl 2 -soluble fraction (4.0 g) was subjected to open column chromatography over silica gel (30 g ) eluted with n-hexane-acetone gradient. Fractions (GF-MC-A to GF-MC-U) were collected and pooled according to their similar TLC patterns. GF-MC-G (176 mg) was chromatographed on a reverse-phase column (1.6ϫ45 cm, RP-C18) with MeOH-H 2 O (55 : 45) to afford GF-MC-G-1. GF-MC-G-1 was purified with silica gel column (1.5ϫ45 cm) with n-hexane-acetone (8 : 1) to afford (5E,7E)-9-oxodeca-5,7-dienoic acid (11, 25 mg). GF-MC-E (175 mg) was chromatographed on a reverse-phase column (1.5ϫ40 cm, RP-C18) with MeOH-H 2 O (80 : 20) to afford GF-MC-E-2. GF-MC-E-2 was purified with silica gel column (1.2ϫ40 cm) with n-hexane-acetone (10 : 1) to afford (Z)-3-ethylidene-4-methylpyrrolidine-2,5-dione (12, 10 mg). GF-MC-E (466 mg) was chromatographed on a reverse-phase column (2.0ϫ45 cm, RP-C18) with MeOH-H 2 O (60 : 40) to afford GF-MC-F-3 and GF-MC-F-4. GF-MC-F-4 was chromatographed on a reverse-phase column (1.2ϫ40 cm, RP-C18) with MeOH-H 2 O (75 : 25) to afford dehydrovomifoliol (13, 30 mg) . GF-MC-F-3 was chromatographed on a reverse-phase column (1.2ϫ40 cm, RP-C18) with MeOH-H 2 O (75 : 25) to afford loliolide (14, 20 mg).
The n-hexane soluble fraction (119.1 g) was subjected to flash column chromatography over silica gel (2.0 kg) eluted with n-hexane-acetone gradient. Fractions (GF-HE-A to GF-HE-U) were collected and pooled according to their similar TLC patterns. GF-HE-C (12.0 g) was chromatographed on a silica gel column (7.8ϫ50 cm) with n-hexane-acetone (gradient from 10 : 1 to 1 : 1) to afford GF-HE-C-1 and GF-HE-C-4. GF-HE-C-1 was chromatographed on a reverse-phase column (1.2ϫ40 cm, RP-C18) with MeOH-H 2 O (75 : 25) to afford cholesteryl stearate (15, 5 mg). GF-HE-C-4 was chromatographed on a reverse-phase column (3.0ϫ50 cm, RP-C18) with MeOH-H 2 O (77 : 23) to afford palmitic acid (16, 4 .0 g). GF-HE-D (6.0 g) and GF-HE-E (6.1 g) were recrystallized to afford 1.0 g and 3.0 g of cholesterol (6), respectively. GF-HE-F (3.1 g) was chromatographed on a reverse-phase column (3.5ϫ50 cm, RP-C18) with MeOH-H 2 O (80 : 20) to afford GF-HE-F-11 and GF-HE-F-13. GF-HE-F-13 was chromatographed on a reverse-phase column (2.4ϫ40 cm, RP-C18) with MeOH-H 2 O (76 : 24) to afford cis -5,8,11,14,17- 
